TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Revenue

In the year 2023, TScan Therapeutics had annual revenue of $21.05M with 55.52% growth. Revenue in the quarter ending December 31, 2023 was $7.21M with 132.99% year-over-year growth.

• Revenue (ttm): $21.05M
• Revenue Growth: +55.52%
• P/S Ratio: 15.16
• Revenue / Employee: $136,682
• Employees: 154
• Market Cap: 319.19M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	21.05M	7.51M	55.52%
Dec 31, 2022	13.54M	3.39M	33.47%
Dec 31, 2021	10.14M	9.06M	834.65%
Dec 31, 2020	1.09M	-	-
Dec 31, 2019	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.